Date Filed | Type | Description |
10/13/2023 |
8-K
| Quarterly results |
10/05/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
09/29/2023 |
10-Q/A
| Quarterly Report for the period ended June 30, 2023 [amend] |
08/08/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
07/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
07/19/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
07/19/2023 |
8-K
| Quarterly results |
06/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
05/11/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
04/19/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
04/19/2023 |
8-K
| Quarterly results |
03/31/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
03/31/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
03/22/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
02/22/2023 |
8-K
| Quarterly results |
02/14/2023 |
SC 13G
| PRICE T ROWE ASSOCIATES INC reports a 5.3% stake in ELEVANCE HEALTH INC |
02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9% stake in Elevance Health Inc. |
02/08/2023 |
8-K
| Quarterly results |
01/30/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
01/30/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
01/27/2023 |
SC 13G/A
| BlackRock Inc. reports a 9% stake in Elevance Health, Inc. |
01/25/2023 |
8-K
| Quarterly results |
11/15/2022 |
SC 13G
| Elevance Health, Inc. reports a 10% stake in GoHealth, Inc. |
11/04/2022 |
8-K
| Quarterly results |
10/27/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
10/26/2022 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
10/26/2022 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
10/25/2022 |
8-K
| Quarterly results |
10/19/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
10/19/2022 |
8-K
| Quarterly results |
07/20/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
07/20/2022 |
8-K
| Quarterly results |
06/28/2022 |
8-K
| Quarterly results |
06/24/2022 |
11-K
| Form 11-K - Annual report of employee stock purchase, savings and similar plans: |
|